Biolidics Receives SGX Approval to List 946 Million Share

MT Newswires
2024-09-30

Biolidics (SGX:8YY) has received the listing and quotation notice from the Singapore Exchange to list and quote 946 million new shares, according to a Monday filing on the Singapore Exchange.

This includes 452 million shares to shareholders Yuan Zhijun and Wu Kunwei, 407 million subscription shares to Zhu Hua, 76 million sign on shares to Chen Lu, and 11 million to Icon Law LLC.

The company must place out these shares within seven market days.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10